Search research articles
Contact Us
Filters
Showing results (141-150 of 162) with videos related to
Page
of 17
Sort By:
Urologic Nursing
|
August 31, 2006
Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer
Mark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urology
|
February 24, 2009
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB
Nathan Bittner, Gregory S Merrick, Hugo Andreini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2005
Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity
Zachariah A Allen, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy
L Christine Fang, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2009
Erectile function durability following permanent prostate brachytherapy
Al V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology
|
December 9, 2008
Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer
Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2005
Erectile function after prostate brachytherapy
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
February 8, 2007
Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry
Gregory S Merrick, Peter D Grimm, John Sylvester, et al.
Medical Physics
|
May 18, 2017
Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]
Mark J Rivard, Wayne M Butler, Larry A DeWerd, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 162) with videos related to
Sort By:
Page
of 17
Urologic Nursing
|
August 31, 2006
Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer
Mark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urology
|
February 24, 2009
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB
Nathan Bittner, Gregory S Merrick, Hugo Andreini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2005
Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity
Zachariah A Allen, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy
L Christine Fang, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2009
Erectile function durability following permanent prostate brachytherapy
Al V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology
|
December 9, 2008
Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer
Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2005
Erectile function after prostate brachytherapy
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
February 8, 2007
Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry
Gregory S Merrick, Peter D Grimm, John Sylvester, et al.
Medical Physics
|
May 18, 2017
Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]
Mark J Rivard, Wayne M Butler, Larry A DeWerd, et al.
Page
of 17